Column Group Iii Gp, Lp - Net Worth and Insider Trading

Column Group Iii Gp, Lp Net Worth

The estimated net worth of Column Group Iii Gp, Lp is at least $109 Million dollars as of 2024-04-29. Column Group Iii Gp, Lp is the 10% Owner of Tenaya Therapeutics Inc and owns about 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $104 Million. Column Group Iii Gp, Lp is also the 10% Owner of Surrozen Inc and owns about 627,652 shares of Surrozen Inc (SRZN) stock worth over $6 Million. Details can be seen in Column Group Iii Gp, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Column Group Iii Gp, Lp has not made any transactions after 2024-04-04 and currently still holds the listed stock(s).

Transaction Summary of Column Group Iii Gp, Lp

To

Column Group Iii Gp, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Column Group Iii Gp, Lp owns 6 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Revolution Medicines Inc (RVMD) , and Constellation Pharmaceuticals Inc (CNST) among others .

Click here to see the complete history of Column Group Iii Gp, Lp’s form 4 insider trades.

Insider Ownership Summary of Column Group Iii Gp, Lp

Ticker Comapny Transaction Date Type of Owner
NGM NGM Biopharmaceuticals Inc 2019-10-14 10 percent owner & other: General Partner
RVMD Revolution Medicines Inc 2020-11-16 10 percent owner
CNST Constellation Pharmaceuticals Inc 2020-03-19 10 percent owner & other: General Partner
SRZN Surrozen Inc 2024-04-04 10 percent owner
TNYA Tenaya Therapeutics Inc 2024-02-12 10 percent owner
CHFW.U Consonance-HFW Acquisition Corp 2021-08-11 10 percent owner

Column Group Iii Gp, Lp Latest Holdings Summary

Column Group Iii Gp, Lp currently owns a total of 2 stocks. Among these stocks, Column Group Iii Gp, Lp owns 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) as of February 12, 2024, with a value of $104 Million and a weighting of 94.84%. Column Group Iii Gp, Lp also owns 627,652 shares of Surrozen Inc (SRZN) as of April 4, 2024, with a value of $6 Million and a weighting of 5.16%.

Latest Holdings of Column Group Iii Gp, Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNYA Tenaya Therapeutics Inc 2024-02-12 22,999,565 4.51 103,785,537
SRZN Surrozen Inc 2024-04-04 627,652 9.00 5,648,868

Holding Weightings of Column Group Iii Gp, Lp


Column Group Iii Gp, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Column Group Iii Gp, Lp has made a total of 6 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,222,222 shares on February 12, 2024, which cost Column Group Iii Gp, Lp around $10 Million.

According to the SEC Form 4 filings, Column Group Iii Gp, Lp has made a total of 2 transactions in Surrozen Inc (SRZN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Surrozen Inc is the acquisition of 193,548 shares on April 4, 2024, which cost Column Group Iii Gp, Lp around $3 Million.

Insider Trading History of Column Group Iii Gp, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Column Group Iii Gp, Lp Trading Performance

GuruFocus tracks the stock performance after each of Column Group Iii Gp, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group Iii Gp, Lp is 80.72%. GuruFocus also compares Column Group Iii Gp, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group Iii Gp, Lp within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Column Group Iii Gp, Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Column Group Iii Gp, Lp

Average Return

57.11%

Average return per transaction

Outperforming Transactions

80%

4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.95 80.72 102.8 57.11
Relative Return to S&P 500(%) 0.55 75.66 90.02 34.16

Column Group Iii Gp, Lp Ownership Network

Ownership Network List of Column Group Iii Gp, Lp

No Data

Ownership Network Relation of Column Group Iii Gp, Lp


Column Group Iii Gp, Lp Owned Company Details

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Column Group Iii Gp, Lp is the 10 percent owner & other: General Partner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Column Group Iii Gp, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 2,247,495 shares made by Column Group L P , a net purchase of 753,345 shares made by David V Goeddel , and a net sale of 85,082 shares made by Jin-long Chen .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,082 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 3,000,840 shares were bought by its insiders, resulting in a net purchase of 2,915,758 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

Column Group Iii Gp, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Column Group Iii Gp, Lp. You might contact Column Group Iii Gp, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on Column Group Iii Gp, Lp

No discussions yet.